187 related articles for article (PubMed ID: 37640958)
1. Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables.
Bizjak DA; Nussbaumer D; Winkert K; Treff G; Takabajashi K; Mentz L; Schober F; Buhl JL; John L; Dreyhaupt J; Steeb L; Harps LC; Parr MK; Diel P; Zügel M; Steinacker JM
Sports Med Open; 2023 Aug; 9(1):79. PubMed ID: 37640958
[TBL] [Abstract][Full Text] [Related]
2. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
[TBL] [Abstract][Full Text] [Related]
3. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
4. β
Jessen S; Reitelseder S; Kalsen A; Kreiberg M; Onslev J; Gad A; Ørtenblad N; Backer V; Holm L; Bangsbo J; Hostrup M
J Appl Physiol (1985); 2021 Mar; 130(3):617-626. PubMed ID: 33357007
[TBL] [Abstract][Full Text] [Related]
5. Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial.
Eckerström F; Rex CE; Maagaard M; Rubak S; Hjortdal VE; Heiberg J
BMJ Open Sport Exerc Med; 2018; 4(1):e000397. PubMed ID: 30233808
[TBL] [Abstract][Full Text] [Related]
6. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
7. Acute impact of inhaled short acting b2-agonists on 5 km running performance.
Dickinson J; Hu J; Chester N; Loosemore M; Whyte G
J Sports Sci Med; 2014 May; 13(2):271-9. PubMed ID: 24790479
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
9. The ergogenic effect of long-term use of high dose salbutamol.
Dickinson J; Molphy J; Chester N; Loosemore M; Whyte G
Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697
[TBL] [Abstract][Full Text] [Related]
10. Combinatory in vitro effects of the β2-agonists salbutamol and formoterol in skeletal muscle cells.
Piribauer M; Jiang L; Kostov T; Parr M; Steidel S; Bizjak DA; Steinacker JM; Diel P
Toxicol Lett; 2023 Apr; 378():10-18. PubMed ID: 36822333
[TBL] [Abstract][Full Text] [Related]
11. The effects of long-acting β2-agonists plus inhaled corticosteroids for early reversibility in patients with airway obstruction.
Ozkaya S; Dirican A; Tuna T
J Thorac Dis; 2013 Aug; 5(4):461-5. PubMed ID: 23991303
[TBL] [Abstract][Full Text] [Related]
12. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
Aziz I; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
Cazzola M; Donner CF
Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
[TBL] [Abstract][Full Text] [Related]
14. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
Kalsen A; Hostrup M; Bangsbo J; Backer V
Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
[TBL] [Abstract][Full Text] [Related]
15. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
16. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
17. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
18. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
[TBL] [Abstract][Full Text] [Related]
19. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.
Geake JB; Dabscheck EJ; Wood-Baker R; Cates CJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010139. PubMed ID: 25575340
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
Koch S; Karacabeyli D; Galts C; MacInnis MJ; Sporer BC; Koehle MS
J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
